Halozyme (HALO) EBITDA margin US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
EBITDA margin, % | ? | 53.9% | 62.2% | 47.8% | 47.1% | 50.9% | 53.4% | |
Changes by years, y/y, % | +88pp | +8pp | -14pp | -1pp | +4pp |
Halozyme. EBITDA margin, %
Halozyme. EBITDA margin, changes, pp
Halozyme (HALO) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA margin, % | ? | 44.2% | 52.1% | 50.3% | 52.9% | 59.1% | 53.4% | |
Changes by years, y/y, % | -21pp | +21pp | -4pp | +9pp | +15pp | |||
Changes by quarters, q/q, % | +1pp | +8pp | -2pp | +3pp | +6pp |